These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11428931)

  • 1. Synthesis and biological activity of 7-oxo substituted analogues of 5-deaza-5,6,7,8-tetrahydrofolic acid (5-DATHF) and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF).
    Borrell JI; Teixidó J; Matallana JL; Martínez-Teipel B; Colominas C; Costa M; Balcells M; Schuler E; Castillo MJ
    J Med Chem; 2001 Jul; 44(14):2366-9. PubMed ID: 11428931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of 4-amino-7-oxo-substituted analogues of 5-deaza-5,6,7,8-tetrahydrofolic acid and 5,10-dideaza-5, 6,7,8-tetrahydrofolic acid.
    Borrell JI; Teixidó J; Martínez-Teipel B; Matallana JL; Copete MT; Llimargas A; García E
    J Med Chem; 1998 Aug; 41(18):3539-45. PubMed ID: 9719607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of 5-deaza-5,6,7,8-tetrahydrofolic acid and its N10-substituted analogues.
    Taylor EC; Hamby JM; Shih C; Grindey GB; Rinzel SM; Beardsley GP; Moran RG
    J Med Chem; 1989 Jul; 32(7):1517-22. PubMed ID: 2738886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antifolate activity of 5-methyl-5,10-dideaza analogues of aminopterin and folic acid and an alternative synthesis of 5,10-dideazatetrahydrofolic acid, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
    Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Thorndike J; Sirotnak FM
    J Med Chem; 1988 Nov; 31(11):2164-9. PubMed ID: 3184124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side chain modified 5-deazafolate and 5-deazatetrahydrofolate analogues as mammalian folylpolyglutamate synthetase and glycinamide ribonucleotide formyltransferase inhibitors: synthesis and in vitro biological evaluation.
    Rosowsky A; Forsch RA; Reich VE; Freisheim JH; Moran RG
    J Med Chem; 1992 May; 35(9):1578-88. PubMed ID: 1578484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.
    Marsilje TH; Labroli MA; Hedrick MP; Jin Q; Desharnais J; Baker SJ; Gooljarsingh LT; Ramcharan J; Tavassoli A; Zhang Y; Wilson IA; Beardsley GP; Benkovic SJ; Boger DL
    Bioorg Med Chem; 2002 Aug; 10(8):2739-49. PubMed ID: 12057663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological properties of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid.
    Boschelli DH; Webber S; Whiteley JM; Oronsky AL; Kerwar SS
    Arch Biochem Biophys; 1988 Aug; 265(1):43-9. PubMed ID: 3166364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of acyclic analogues of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid.
    Shih C; Gossett LS; Worzalla JF; Rinzel SM; Grindey GB; Harrington PM; Taylor EC
    J Med Chem; 1992 Mar; 35(6):1109-16. PubMed ID: 1552503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thienyl and thiazolyl acyclic analogues of 5-deazatetrahydrofolic acid.
    Hodson SJ; Bigham EC; Duch DS; Smith GK; Ferone R
    J Med Chem; 1994 Jun; 37(13):2112-5. PubMed ID: 8027993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase.
    Baldwin SW; Tse A; Gossett LS; Taylor EC; Rosowsky A; Shih C; Moran RG
    Biochemistry; 1991 Feb; 30(7):1997-2006. PubMed ID: 1993209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.
    Zhang Y; Desharnais J; Marsilje TH; Li C; Hedrick MP; Gooljarsingh LT; Tavassoli A; Benkovic SJ; Olson AJ; Boger DL; Wilson IA
    Biochemistry; 2003 May; 42(20):6043-56. PubMed ID: 12755606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
    Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
    J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
    Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 5-deazaisofolic acid, 5-deaza-5,6,7,8-tetrahydroisofolic acid, and their N9-substituted analogues.
    Singh SK; Dev IK; Duch DS; Ferone R; Smith GK; Freisheim JH; Hynes JB
    J Med Chem; 1991 Feb; 34(2):606-10. PubMed ID: 1995883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of an acyclic analogue of 5,6,7,8-tetrahydrofolic acid, N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-5- pyrimidinyl)propyl]amino]-benzoyl]-L-glutamic acid.
    Kelley JL; McLean EW; Cohn NK; Edelstein MP; Duch DS; Smith GK; Hanlon MH; Ferone R
    J Med Chem; 1990 Feb; 33(2):561-7. PubMed ID: 2299624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of alpha- and gamma-carboxamide derivatives of 10-CF3CO-DDACTHF.
    Chong Y; Hwang I; Tavassoli A; Zhang Y; Wilson IA; Benkovic SJ; Boger DL
    Bioorg Med Chem; 2005 May; 13(10):3587-92. PubMed ID: 15848771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antifolate properties of 10-alkyl-5,10-dideaza analogues of methotrexate and tetrahydrofolic acid.
    DeGraw JI; Christie PH; Kisliuk RL; Gaumont Y; Sirotnak FM
    J Med Chem; 1990 Feb; 33(2):673-7. PubMed ID: 2299633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5,10-Dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF): a potent inhibitor of purine biosynthesis.
    Nutr Rev; 1990 Nov; 48(11):421-3. PubMed ID: 2080047
    [No Abstract]   [Full Text] [Related]  

  • 20. The synthesis and biological activity of a series of 2,4-diaminopyrido[2,3-d]pyrimidine based antifolates as antineoplastic and antiarthritic agents.
    Gossett LS; Habeck LL; Shackelford KA; Mendelsohn LG; Gates SB; Worzalla JF; Self TD; Theobald KS; Andis SL; Schultz RM; Shih C
    Bioorg Med Chem Lett; 1999 Jan; 9(1):75-8. PubMed ID: 9990460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.